The blood-brain barrier of rats was opened reversibly by infusing a hyperosmotic solution of 
Correction. In the article "Repair of O6-methylguanine in adapted Escherichia coli" by Paul F. Schendel and Peter E. Robins, which appeared in the December 1978 issue of Proc. Natl. Acad. Sci. USA (75, (6017) (6018) (6019) (6020) , the authors request the following change. The units given for the left vertical axis of Fig. 2 should be cpm in O6MeGua/3 X 107 cells.
Correction. In the article "Modification of the blood-brain barrier: Increased concentration and fate of enzymes entering the brain" by John A. Barranger, Stanley I. Rapoport, Wendy R. Fredericks, Peter G. Pentchev, Kaye D. MacDermot, Jan K. Steusing, and Roscoe O. Brady, which appeared in the January 1979 issue of the Proc. Natl. Acad. Sci. USA (76, 481-485), the authors wish the following correction to be made. On page 485, line 1 of the left-hand column, ref. 18 should be deleted and added on page 484 to the end of line 8 from the bottom of the right-hand column so that the references in these parentheses will be " (18, 20) ." by the corresponding zones of the colony. On the bottom are computer-drawn topological contours of a typical colony grown in 10% FCS on day 14 (mounding index <0) (Left) and another colony with the addition of insulin at 50 ng/ml (mounding index > 0) (Right). The vertical axis is exaggerated.
Corrections
The blkod-brain barrier at cerebral blood vessels is due to a continuous layer of endothelial cells bound together by tight junctions. The cells show little or no transendothelial vesicular transport. Because tight junctions prevent intercellular diffusion, the barrier restricts brain-blood exchange of water-soluble drugs, ions, and proteins, although lipid-soluble agents easily enter the brain (1-3) .
The blood-brain barrier can be altered experimentally by a number of different methods (1, 4) . One of these is osmotic barrier opening, which, unlike most other methods, is reversible and is unaccompanied by evidence of gross neurological injury (5, 6) . Osmotic barrier opening most likely is caused by shrinkage of cerebrovascular endothelial cells and increased permeability of interendothelial tight junctions (ref. 7 and unpublished data). Permeability is increased to the Evans blue dye-albumin complex (Mr 78,000) and to neutralizing antibody (IgG) to measles virus (Mr 180,000). Antibody that is allowed into the brain retains activity for up to 4 days (8) .
The observation that the blood-brain barrier can be opened reversibly in laboratory animals without gross injury led us to consider introducing an intravascularly administered lysosomal enzyme into the brain and to examine its cerebral disposition in an intact animal. This report presents the results of these studies and describes the intensity and time course of barrier modification. Some of the work has been reported in preliminary form (9 Modification of Blood-Brain Barrier. Male SpragueDawley rats weighing 250-350 g were anesthetized with sodium pentobarbital (50 mg/kg intraperitoneally). The skin of the neck was incised and the external carotid artery was exposed and freed of connective tissue. A polyethylene catheter (PE 50), filled with 0.9% (wt/vol) NaCl plus 100 international units of Na heparin per ml, was tied into the external carotid artery for retrograde infusion. The mouth of the catheter was placed 2 mm from the bifurcation of the common carotid. A solution of 1.6 molal arabinose, warmed to 370C, was infused through the catheter for 30 sec, at a rate of 0.12 ml/sec, by means of a constant flow pump. Direct observation of the carotid artery tree revealed that infusate passed into the brain via the internal carotid artery without flowing down into the common carotid.
Evans blue dye-albumin (0.5 ml of 2% solution) was given intravenously 5 min prior to carotid infusion. Entry of dye into the brain ipsilateral to carotid infusion served as a positive marker of barrier alteration, which was graded from grade 0 (no brain staining by Evans blue) to 3+ (deep blue staining). Only animals with a grade 2+ or 3+ staining, comprising 85% of experiments, were used for further analysis.
Time Course of Barrier Modification. Previous studies qualitatively demonstrated that osmotic barrier opening to intravascular Evans blue-albumin was reversible. In the present study, we used a recently reported method (10) to quantitatively determine the time course of increased cerebrovascular permeability after 1.6 m arabinose infusion. Five microcuries of [14C]sucrose (specific activity 4.9 Ci/mol) was injected intravenously at the following times after carotid infusion: 5 min, 30 min, 60 min, 120 min, 1 day, and 2 days. Plasma radioactivity was followed for 10 min after tracer was injected. When the animal was killed, three regions of the ipsilateral brain were dissected and prepared for measurement of radioactivity.
Preparation of a-Mannosidase. a-Mannosidase (a-Dmannoside mannohydrolase, EC 3.2.1.24) was prepared from human placenta by using columns containing concanavalin A
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. §1734 solely to indicate this fact. and DEAE to enrich the enzyme 1000-fold over the starting concentration (unpublished observations labeled albumin (17) . Cerebral capillary permeability was measured in different regions of the brain with ['4C]sucrose and it was shown to be independent of possible changes in regional blood flow (10) . This method was used to determine the time course of increased cerebrovascular permeability in four brain regions after carotid infusion of 1.6 molal arabinose. Fig. 1 enzyme activity equaled 900 units/ml, total intravascular activity at 2 hr would be about 27 units/g of brain, as compared to background of approximately 3000 units/g in brain tissue itself. This activity in the control contralateral hemibrain in the animals that were treated osmotically and infused with amannosidase was the same as in animals not receiving enzyme. The average increase in a-mannosidase activity after hypertonic infusion was 2100 units/g of brain for a dose of 5 X 105 units of enzyme per animal (Table 1) . Permeability was significantly altered for only the first 30 min after carotid infusion (Fig. 1) . During this time, the serum concentration of enzyme was essentially constant at 35,000 units/ml. Data presented below indicate that the enzyme initially was found in the brain extracellular space, which constitutes about 20% of wet weight of the brain (1, 18) . Taking these points into account, the brain space into which the enzyme distributed can be calculated as 6% of brain weight (2100 units/g of brain)/(35,000 units/ml of serum); the fraction of extracellular space filled by enzyme can then be calculated as 30% or 6/20.
Disposition of Exogenous Enzyme within Brain. In order to eliminate possible errors due to endogenous enzyme activity, we used peroxidase to study intracerebral disposition and cellular uptake of enzymes. The blood-brain barrier was opened by infusion of 1.6 molal arabinose in the right carotid artery, and peroxidase was injected intravenously as a bolus. Two hours later, enzyme activity was readily demonstrated in homogenates of the ipsilateral, but not in the contralateral, hemibrain (Table 2) . Centrifugation at 100,000 X g for 30 min showed that most of the peroxidase was in the supernatant fraction 2 hr after hypertonic arabinose infusion. Animals killed at later times had measurable peroxidase activity in the particulate fraction. The amount of activity associated with the particulate fraction increased with time up to 72 hr (Fig. 2) . By 24 hr, over 90% of recovered activity was associated with the 100,000 X g pellet. Addition of 500-5000 units of peroxidase to homogenates of 1 g of control brain tissue did not result in more than trace amounts of activity associated with the particulate fraction. Similar results were obtained when [14C]mannitol or [14C]-dextran was homogenized with control hemibrain. These findings indicate that the peroxidase associated with the particulate fraction was incorporated into an organized particle within brain cells.
Histochemistry of cortical sections of perfused hemibrain supported this interpretation (Fig. 3) . Dense peroxidase staining of granular material was evident in the cytoplasm and axonal projections of cerebral cortical neurons. The nuclei apparently did not stain. No cells were stained in the contralateral cortex, where the barrier remained intact. Staining, which was evident in the right cerebral cortex of animals killed 72 hr after hypertonic infusion, was qualitatively less than at 48 hr, which in turn was less than at 24 hr. Interstitial staining was marked at 2 hr and barely visible at 24 hr. Thus, peroxidase was slowly disposed of by the brain.
Differential centrifugation of brain homogenates showed that peroxidase activity was associated with the particulate fraction containing lysosomal enzyme markers (Fig. 4) and, to some extent, with the nuclear fraction. A small amount of lactate dehydrogenase was associated with this nuclear fraction, which light microscopy demonstrated to be devoid of whole cells. Preliminary electron microscopic examination revealed membrane-bound, peroxidase-positive particles in both the nuclear and lysosomal fractions (unpublished observations). The recovered activity from the nuclear and lysosomal fractions (18, 19, (21) (22) (23) . Systemically administered peroxidase can be taken up in membrane-bound vesicles at peripheral nerve endings, which then are transported in a retrograde direction into central nerve-cell bodies of cranial nerves (19) . As the peroxidase-laden particles enter the axon hillock, they become positive in acid phosphatase, whereas they are not positive in the peripheral nerves (24) . Our results show that enzyme entering the brain after osmotic barrier opening can be incorporated into particles of neuronal cell bodies and their processes. Studies with intracerebral injection of peroxidase have demonstrated uptake at axon terminals and retrograde transport to cell bodies (21) . Whether the appearance of peroxidase in neurons proceeds by direct uptake into cell bodies or by retrograde transport or both is not addressed by our experiments.
The apparent lack of peroxidase staining in glial elements is provocative. This could represent rapid disposition of the enzyme by glial cells such that sampling at 2 hr or later might not reveal their involvement. On the other hand, the absence of peroxidase activity in glia could indicate a specific process in neurons. Peroxidase is a glycoprotein rich in mannosyl residues. Specific receptors for mannose-terminal glycoproteins have been demonstrated in cells of non-neural tissue (25, 26) . The possibility exists that a similar mannosyl-specific receptor is present on neuronal membranes.
The appearance of peroxidase in the crude nuclear fraction has been seen before in experiments attempting to follow the fate of intravenously administered enzymes (27) (28) (29) , but no satisfying explanation for it is evident. One possibility is that so-called "endocytotic vacuoles" or complete lysosomes coalesce into particles whose specific gravity equals that of nuclei. The observation that this fraction, as well as the lysosomal fraction, demonstrate latency supports this hypothesis.
In summary, we have shown that a significant amount of a human lysosomal enzyme enters the brain after osmotic barrier opening, and we have suggested that this amount may be further augmented by administering the enzyme via an intracarotid rather than an intravenous route. Increased enzymatic activity remains in the brain for up to 72 hr and is localized within neuronal lysosomes. These findings provide encouragement for the possibility of enzyme replacement therapy in inborn deficiencies of lysosomal enzymes involving the brain.
